The Torino Pericarditis Score: a new-risk stratification tool to predict complicated pericarditis.
Pericarditis
Prognosis
Score
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
05
04
2021
accepted:
03
07
2021
pubmed:
19
7
2021
medline:
23
11
2021
entrez:
18
7
2021
Statut:
ppublish
Résumé
Current guidelines on the management of pericardial diseases suggest to identify high-risk features associated with an increased risk of non-idiopathic aetiology and complications. The aim of this study is to evaluate a "pericarditis score" to assess potential complicated pericarditis in order to facilitate initial clinical triage. Consecutive patients with pericarditis were included in a prospective cohort study from January 2017 to December 2018. Complicated pericarditis was defined as pericarditis with a non-idiopathic aetiology, and/or complications, and/or requiring hospitalization. A clinical and echocardiographic follow-up were performed at 1, 3, 6 months and then every 6 months. The study population was randomized in derivation and validation cohorts. In the derivation cohort, female gender (HR 2.57, p = 0.016), fever > 38 °C (HR 2.86, p = 0.005), previous lack of colchicine use (HR 3.16, p = 0.006), previous use of corticosteroids (HR 3.01, p = 0.009), and echocardiographic signs of constriction (HR 2.26, p = 0.018) were selected by a stepwise procedure in a Cox regression model and constituted the score showing a C-statistics of 0.81. In the validation group, the score was significantly associated with the risk of complicated pericarditis (HR 1.438 per 10-points increase, 95% CI 1.208-1.711, p < 0.001) and showed an increase in event rate with increasing score (low risk ≤ 20 points: complicated pericarditis in 4/19 patients, incidence 21%, p = 0.003, high risk > 40 points: complicated pericarditis in 18/24 patients, incidence 75%, p = 0.006). In this study, we developed and tested a simple score to efficiently identify at presentation patients at high risk of developing complicated pericarditis.
Identifiants
pubmed: 34275095
doi: 10.1007/s11739-021-02803-y
pii: 10.1007/s11739-021-02803-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1921-1926Informations de copyright
© 2021. Società Italiana di Medicina Interna (SIMI).
Références
Adler Y, Charron P, Imazio M et al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2964. https://doi.org/10.1093/eurheartj/ehv318
doi: 10.1093/eurheartj/ehv318
pubmed: 26320112
pmcid: 26320112
Imazio M, Cecchi E, Demichelis B et al (2007) Indicators of poor prognosis of acute pericarditis. Circulation 115:2739–2744. https://doi.org/10.1161/CIRCULATIONAHA.106.662114
doi: 10.1161/CIRCULATIONAHA.106.662114
pubmed: 17502574
Imazio M, Demichelis B, Parrini I et al (2004) Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol 43:1042–1046. https://doi.org/10.1016/j.jacc.2003.09.055
doi: 10.1016/j.jacc.2003.09.055
Andreis A, Imazio M, Casula M et al (2021) Recurrent pericarditis: an update on diagnosis and management. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02639-6
doi: 10.1007/s11739-021-02639-6
pubmed: 34275095
pmcid: 7947153
Artom G, Koren-Morag N, Spodick DH et al (2005) Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur Heart J 26:723–727. https://doi.org/10.1093/eurheartj/ehi197
doi: 10.1093/eurheartj/ehi197
pubmed: 15755753
Imazio M, Gaita F, LeWinter M (2015) Evaluation and treatment of pericarditis: a systematic review. JAMA 314:1498–1506. https://doi.org/10.1001/jama.2015.12763
doi: 10.1001/jama.2015.12763
pubmed: 26461998
Imazio M, Brucato A, Cemin R et al (2013) A randomized trial of colchicine for acute pericarditis. N Engl J Med 369:1522–1528. https://doi.org/10.1056/NEJMoa1208536
doi: 10.1056/NEJMoa1208536
pubmed: 23992557
Imazio M, Belli R, Brucato A et al (2014) Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet Lond Engl 383:2232–2237. https://doi.org/10.1016/S0140-6736(13)62709-9
doi: 10.1016/S0140-6736(13)62709-9
Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671. https://doi.org/10.1161/CIRCULATIONAHA.107.761064
doi: 10.1161/CIRCULATIONAHA.107.761064
pubmed: 18645054
Bayes-Genis A, Adler Y, de Luna AB, Imazio M (2017) Colchicine in pericarditis. Eur Heart J 38:1706–1709. https://doi.org/10.1093/eurheartj/ehx246
doi: 10.1093/eurheartj/ehx246
pubmed: 30052886
Imazio M, Brucato A, Maestroni S et al (2011) Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 123:1092–1097. https://doi.org/10.1161/CIRCULATIONAHA.110.986372
doi: 10.1161/CIRCULATIONAHA.110.986372
pubmed: 21357824
Andreis A, Imazio M, Giustetto C et al (2020) Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis. Heart Br Card Soc 106:1561–1565. https://doi.org/10.1136/heartjnl-2020-316898
doi: 10.1136/heartjnl-2020-316898
Cosyns B, Plein S, Nihoyanopoulos P et al (2015) European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging 16:12–31. https://doi.org/10.1093/ehjci/jeu128
doi: 10.1093/ehjci/jeu128
pubmed: 25248336
pmcid: 25248336